For the year ending 2025-12-31, IMCR has $1,067,269K in assets. $686,236K in debts. $467,709K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 467,709 | |||
| Marketable securities | 396,444 | |||
| Accounts receivable, net | 73,977 | |||
| Prepaid expenses and other current assets | 50,055 | |||
| Tax receivable | 1,815 | |||
| Inventory, net | 6,742 | |||
| Total current assets | 996,742 | |||
| Property and equipment, net | 11,462 | |||
| Operating lease right of use assets, net | 38,783 | |||
| Deferred tax assets, net | 0 | |||
| Other non-current assets | 20,282 | |||
| Total assets | 1,067,269 | |||
| Accounts payable | 24,364 | |||
| Accrued expenses and other current liabilities | 219,744 | |||
| Deferred revenue, current | 583 | |||
| Operating lease liabilities, current | 2,006 | |||
| Total current liabilities | 246,697 | |||
| Deferred revenue, non-current | 4,858 | |||
| Operating lease liabilities, non-current | 41,556 | |||
| Interest-bearing loans and borrowings | 393,125 | |||
| Total liabilities | 686,236 | |||
| Ordinary shares (voting and non-voting), 0.002 par value, most recent authority to allot up to a maximum nominal value of 149,633 and 97,454 shares as of december31, 2025 and 2024, respectively, and 50,689,271 and 50,064,860 shares issued and outstanding as of december31, 2025 and 2024, respectively | 136 | |||
| Deferred shares, 0.0001 par value, 5,793,501 shares authorized, issued and outstanding as of december31, 2025 and 2024 | 1 | |||
| Additional paid-in capital | 1,240,255 | |||
| Accumulated deficit | -831,275 | |||
| Accumulated other comprehensive loss | -28,084 | |||
| Total shareholders equity | 381,033 | |||
| Total liabilities and shareholders equity | 1,067,269 | |||
Immunocore Holdings plc (IMCR)
Immunocore Holdings plc (IMCR)